Skip to main content
. 2011 Dec;49(12):4112–4116. doi: 10.1128/JCM.05195-11

Table 1.

CCs used for second-line antimicrobials in previously published studies and the CCs/test concentrations used in this study

Antimicrobial CC (μg/ml)
B460 Lab 1b Lab 2c Lab 3d Lab 4e Lab 5f NRCM lab Study participant labs
Amikacin 1 1.5 1 1 1 1 0.5, 1.0, 2.0 1
Capreomycin 1.25 3 2.5 2.5 2.5 NTa 1.25, 2.5, 5.0 2.5
Ethionamide 2.5 5 5 5 5 NT 2.5, 5.0, 7.5 5
Kanamycin 5 NT 2.5 NT NT NT 2.5, 5.0, 7.5 2.5, 5.0
Linezolid 1 NT NT 1 1 NT 0.5, 1.0, 2.0 0.5, 1.0, 2.0
Moxifloxacin 0.5 NT 1.0 0.25 NT 0.125 0.25, 0.5, 1.0 0.25, 0.5, 1.0
Ofloxacin 2 NT 2 2 2 1 1.0, 2.0, 4.0 2
PAS 4 NT 4 NT NT NT 2.0, 4.0, 8.0 2.0, 4.0, 8.0
Rifabutin 0.5 NT NT NT 0.5 0.5 0.25, 0.5, 1.0 0.5
a

NT, not tested.

b

Reference 6.

c

Reference 16.

d

Reference 21.

e

Reference 17.

f

Reference 5.